•
Mar 31, 2019

Arrowhead Pharmaceuticals Q2 2019 Earnings Report

Total Revenue
$48.1M
Previous year: $650K
+7306.0%
EPS
$0.24
Previous year: -$0.18
-233.3%
Gross Profit
$48.1M
Previous year: $650K
+7306.0%
Cash and Equivalents
$162M
Previous year: $69.8M
+131.6%
Free Cash Flow
-$19.8M
Previous year: -$15.8M
+25.1%
Total Assets
$334M
Previous year: $127M
+162.9%

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals